Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$27.79 +0.1%	$30.30	$26.25 ▼ $40.49	$14.24B	0.61	4.33 million shs	97,618 shs
PODD Insulet	$285.08 +0.3%	$309.07	$173.00 ▼ $329.33	$20.06B	1.35	777,511 shs	31,322 shs
RMD ResMed	$260.13 +0.9%	$251.53	$196.43 ▼ $263.05	$38.00B	0.77	966,964 shs	12,136 shs
TFX Teleflex	$112.20 +1.0%	$120.71	$110.83 ▼ $249.91	$4.93B	1.08	636,707 shs	4,628 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	0.00%	-3.24%	-7.48%	-2.73%	-21.41%
PODD Insulet	0.00%	-1.76%	-6.24%	+19.14%	+45.74%
RMD ResMed	0.00%	+1.37%	+1.57%	+22.08%	+26.82%
TFX Teleflex	0.00%	-4.53%	-5.80%	-14.03%	-49.87%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAX Baxter International	4.614 of 5 stars	3.2	2.0	1.7	4.0	2.0	1.7	2.5
PODD Insulet	4.6021 of 5 stars	3.4	3.0	0.0	4.9	3.2	0.8	1.9
RMD ResMed	4.2497 of 5 stars	2.4	0.0	3.3	4.6	4.0	1.7	1.3
TFX Teleflex	4.797 of 5 stars	4.0	4.0	2.5	3.9	1.3	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAX Baxter International	2.44	Hold	$36.38	30.92% Upside
PODD Insulet	2.83	Moderate Buy	$321.00	12.60% Upside
RMD ResMed	2.73	Moderate Buy	$263.00	1.11% Upside
TFX Teleflex	2.09	Hold	$159.63	42.27% Upside

Current Analyst Ratings Breakdown

Latest PODD, BAX, TFX, and RMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/16/2025	RMD ResMed	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$250.00 ➝ $270.00
7/16/2025	TFX Teleflex	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$150.00 ➝ $130.00
7/15/2025	BAX Baxter International	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$28.00 ➝ $27.00
7/15/2025	RMD ResMed	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Outperform	$255.00 ➝ $294.00
7/15/2025	TFX Teleflex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Sector Perform ➝ Sector Perform	$145.00 ➝ $130.00
7/9/2025	BAX Baxter International	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$34.00 ➝ $32.00
7/8/2025	PODD Insulet	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/8/2025	BAX Baxter International	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$44.00 ➝ $42.00
6/16/2025	PODD Insulet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$365.00
5/30/2025	PODD Insulet	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$380.00
5/27/2025	PODD Insulet	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$328.00 ➝ $360.00

(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAX Baxter International	$10.77B	1.32	$4.76 per share	5.84	$13.76 per share	2.02
PODD Insulet	$2.07B	9.69	$4.45 per share	64.07	$17.27 per share	16.51
RMD ResMed	$5.02B	7.60	$9.31 per share	27.95	$33.11 per share	7.86
TFX Teleflex	$3.05B	1.63	$25.62 per share	4.38	$92.11 per share	1.22

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAX Baxter International	-$649M	-$1.10	N/A	10.18	0.82	-4.71%	17.24%	5.12%	7/31/2025 (Estimated)
PODD Insulet	$418.30M	$5.56	51.27	57.36	2.54	18.29%	22.25%	8.29%	8/7/2025 (Confirmed)
RMD ResMed	$1.02B	$8.91	29.09	25.11	1.61	26.15%	25.67%	18.59%	7/31/2025 (Estimated)
TFX Teleflex	$69.68M	$3.17	35.21	7.39	1.74	4.96%	14.73%	8.79%	7/31/2025 (Estimated)

Latest PODD, BAX, TFX, and RMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	PODD Insulet	$0.9290	N/A	N/A	N/A	$612.31 million	N/A
7/31/2025	Q2 2025	BAX Baxter International	$0.60	N/A	N/A	N/A	$2.82 billion	N/A
7/31/2025	Q4 2025	RMD ResMed	$2.47	N/A	N/A	N/A	$1.33 billion	N/A
7/31/2025	Q2 2025	TFX Teleflex	$3.36	N/A	N/A	N/A	$771.53 million	N/A
5/8/2025	Q1 2025	PODD Insulet	$0.81	$1.02	+$0.21	$0.50	$543.20 million	$569.00 million
5/1/2025	Q1 2025	BAX Baxter International	$0.48	$0.62	+$0.14	$0.25	$2.59 billion	$2.63 billion
5/1/2025	Q1 2025	TFX Teleflex	$2.88	$2.91	+$0.03	$2.07	$699.37 million	$700.67 million
4/23/2025	Q3 2025	RMD ResMed	$2.36	$2.37	+$0.01	$2.48	$1.28 billion	$1.29 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAX Baxter International	$0.68	2.45%	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A
RMD ResMed	$2.12	0.81%	N/A	23.79%	13 Years
TFX Teleflex	$1.36	1.21%	N/A	42.90%	N/A

Latest PODD, BAX, TFX, and RMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/14/2025	BAX Baxter International	quarterly	$0.17	2.38%	8/29/2025	8/29/2025	10/1/2025
5/6/2025	BAX Baxter International	quarterly	$0.17	2.27%	5/30/2025	5/30/2025	7/1/2025
5/12/2025	TFX Teleflex	quarterly	$0.34	1.09%	5/20/2025	5/20/2025	6/16/2025
4/24/2025	RMD ResMed	quarterly	$0.53	0.9%	5/8/2025	5/8/2025	6/12/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAX Baxter International	1.33	2.02	1.40
PODD Insulet	1.21	4.47	3.63
RMD ResMed	0.12	3.41	2.49
TFX Teleflex	0.44	2.28	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAX Baxter International	90.19%
PODD Insulet	N/A
RMD ResMed	54.98%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
BAX Baxter International	0.21%
PODD Insulet	0.39%
RMD ResMed	0.71%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAX Baxter International	38,000	513.18 million	512.15 million	Optionable
PODD Insulet	3,900	70.38 million	70.10 million	Optionable
RMD ResMed	9,980	146.63 million	145.59 million	Optionable
TFX Teleflex	14,100	44.19 million	43.57 million	Optionable

PODD, BAX, TFX, and RMD Headlines

Recent News About These Companies

Teleflex Incorporated (NYSE:TFX) Shares Sold by Edgestream Partners L.P.

July 20 at 4:23 AM | marketbeat.com

Xponance Inc. Sells 3,943 Shares of Teleflex Incorporated (NYSE:TFX)

July 19 at 4:12 AM | marketbeat.com

Cooke & Bieler LP Trims Stock Position in Teleflex Incorporated (NYSE:TFX)

July 17, 2025 | marketbeat.com

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

July 17, 2025 | globenewswire.com

Mizuho Has Lowered Expectations for Teleflex (NYSE:TFX) Stock Price

July 16, 2025 | marketbeat.com

Brokerages Set Teleflex Incorporated (NYSE:TFX) Price Target at $164.63

July 16, 2025 | americanbankingnews.com

Teleflex Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

July 15, 2025 | benzinga.com

Royal Bank Of Canada Cuts Teleflex (NYSE:TFX) Price Target to $130.00

July 15, 2025 | marketbeat.com

Teleflex (NYSE:TFX) Hits New 52-Week Low - Time to Sell?

July 14, 2025 | marketbeat.com

Louisiana State Employees Retirement System Acquires 19,400 Shares of Teleflex Incorporated (NYSE:TFX)

July 14, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Stock Position Reduced by Bank of New York Mellon Corp

July 14, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Bought by Speece Thorson Capital Group Inc.

July 13, 2025 | marketbeat.com

8,988 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Teacher Retirement System of Texas

July 13, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Given Consensus Recommendation of "Hold" by Brokerages

July 13, 2025 | marketbeat.com

Principal Financial Group Inc. Buys 160,646 Shares of Teleflex Incorporated (NYSE:TFX)

July 8, 2025 | marketbeat.com

Amalgamated Bank Raises Holdings in Teleflex Incorporated (NYSE:TFX)

July 7, 2025 | marketbeat.com

KBC Group NV Trims Stock Position in Teleflex Incorporated (NYSE:TFX)

July 7, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Acquired by New York State Teachers Retirement System

July 6, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Purchased by Oregon Public Employees Retirement Fund

July 5, 2025 | marketbeat.com

Teleflex signs MoU with Fortis Hospitals in India to create a UroLiftTM Center of Education

July 4, 2025 | theprint.inT

Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up

July 3, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PODD, BAX, TFX, and RMD Company Descriptions

Baxter International NYSE:BAX

$27.78 +0.02 (+0.05%)

As of 09:58 AM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Insulet NASDAQ:PODD

$285.08 +0.85 (+0.30%)

As of 09:57 AM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

ResMed NYSE:RMD

$260.12 +2.21 (+0.85%)

As of 09:58 AM Eastern

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Teleflex NYSE:TFX

$112.20 +1.14 (+1.03%)

As of 09:57 AM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time